Correlation Between Protalix Biotherapeutics and RespireRx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Protalix Biotherapeutics and RespireRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protalix Biotherapeutics and RespireRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protalix Biotherapeutics and RespireRx Pharmaceuticals, you can compare the effects of market volatilities on Protalix Biotherapeutics and RespireRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protalix Biotherapeutics with a short position of RespireRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protalix Biotherapeutics and RespireRx Pharmaceuticals.
Diversification Opportunities for Protalix Biotherapeutics and RespireRx Pharmaceuticals
0.01 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Protalix and RespireRx is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Protalix Biotherapeutics and RespireRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RespireRx Pharmaceuticals and Protalix Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protalix Biotherapeutics are associated (or correlated) with RespireRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RespireRx Pharmaceuticals has no effect on the direction of Protalix Biotherapeutics i.e., Protalix Biotherapeutics and RespireRx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Protalix Biotherapeutics and RespireRx Pharmaceuticals
Considering the 90-day investment horizon Protalix Biotherapeutics is expected to generate 16.95 times less return on investment than RespireRx Pharmaceuticals. But when comparing it to its historical volatility, Protalix Biotherapeutics is 3.68 times less risky than RespireRx Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. RespireRx Pharmaceuticals is currently generating about 0.17 of returns per unit of risk over similar time horizon. If you would invest 0.38 in RespireRx Pharmaceuticals on September 5, 2024 and sell it today you would earn a total of 0.32 from holding RespireRx Pharmaceuticals or generate 84.21% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 7.68% |
| Values | Daily Returns |
Protalix Biotherapeutics vs. RespireRx Pharmaceuticals
Performance |
| Timeline |
| Protalix Biotherapeutics |
| RespireRx Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Protalix Biotherapeutics and RespireRx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Protalix Biotherapeutics and RespireRx Pharmaceuticals
The main advantage of trading using opposite Protalix Biotherapeutics and RespireRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protalix Biotherapeutics position performs unexpectedly, RespireRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RespireRx Pharmaceuticals will offset losses from the drop in RespireRx Pharmaceuticals' long position.| Protalix Biotherapeutics vs. Corvus Pharmaceuticals | Protalix Biotherapeutics vs. Aldeyra | Protalix Biotherapeutics vs. Checkpoint Therapeutics | Protalix Biotherapeutics vs. Cidara Therapeutics |
| RespireRx Pharmaceuticals vs. Nascent Biotech | RespireRx Pharmaceuticals vs. Protokinetix | RespireRx Pharmaceuticals vs. Silo Pharma | RespireRx Pharmaceuticals vs. Vg Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stocks Directory Find actively traded stocks across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |